 |
인쇄하기
취소
|
GSK, Daewoong to face class action suit
GlaxoSmithKline (GSK) will face a possible class action suit by a group of patients and consumers saying GSK colluded with Dong-A Pharm to hinder the generic sale of its anti-emetic Zofran for the past 12 years.
They also threatened to file a class action suit against Daewoong Pharm as the company has offered 40 million won in rebates between 2004 and 2006 to promote antifungal agent Plunazo...
They also threatened to file a class action suit against Daewoong Pharm as the company has offered 40 million won in rebates between 2004 and 2006 to promote antifungal agent Plunazo...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.